SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Perrigo business and prospects, resulting in its stock trading at inflated prices. ...

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Perrigo Company plc securities between February 27, 2023, and November 4, 2025, due to alleged misleading statements and undisclosed issues related to the company's infant formula business [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Perrigo made materially false and misleading statements regarding its infant formula business, which suffered from significant underinvestment and required substantial capital expenditures [5]. - Allegations include significant manufacturing deficiencies in the infant formula facility, leading to overstated financial results, including earnings and cash flow [5]. - The lawsuit asserts that when the true details became known, investors suffered damages due to the misleading nature of Perrigo's positive statements about its business and operations [5]. Group 2: Class Action Participation - Investors who purchased Perrigo securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6]. - A lead plaintiff must move the court by January 16, 2026, to represent other class members in the litigation [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its effectiveness in representing investor rights [4].

Core Viewpoint - The article highlights the upcoming deadline of January 16, 2026, for investors to file a lead plaintiff motion in a class action lawsuit concerning Perrigo Company plc, specifically for those who acquired its securities between February 27, 2023, and November 4, 2025 [1] Group 1 - The class action is filed on behalf of investors who purchased or otherwise acquired Perrigo securities during the specified Class Period [1] - Investors who suffered losses on their Perrigo investments are encouraged to inquire about potentially pursuing claims [1]

Core Viewpoint - A class action lawsuit has been filed against Perrigo Company plc, alleging that the company misled investors regarding the value of its infant formula business, leading to significant financial losses for shareholders [1][2]. Allegations - The lawsuit claims that Perrigo failed to disclose critical issues with its infant formula business, including underinvestment in maintenance and operational improvements, the need for substantial capital expenditures beyond stated estimates, and significant manufacturing deficiencies [2]. - As a result of these undisclosed issues, Perrigo's financial results, including earnings and cash flow, were allegedly overstated [2]. Financial Impact - On November 5, 2025, Perrigo announced disappointing third-quarter financial results and slashed its fiscal year 2025 outlook, primarily due to challenges in the infant formula industry [3]. - The company also initiated a strategic review of its infant formula business, reassessing a previously announced investment of $240 million, which was deemed "less strategic" [3]. - Following this announcement, Perrigo's stock price dropped by $5.09, or 25.2%, closing at $15.10 per share on the same day [3].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of investors who purchased securities of Perrigo Company plc during the specified Class Period, highlighting the importance of securing legal counsel before the upcoming deadline for lead plaintiff applications [1][2]. Group 1: Class Action Details - The class action lawsuit pertains to securities purchased between February 27, 2023, and November 4, 2025, and investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2][5]. - Investors wishing to serve as lead plaintiff must file their motion by January 16, 2026, and a lead plaintiff acts on behalf of other class members in directing the litigation [1][3]. Group 2: Allegations Against Perrigo - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business acquired from Nestlé, which suffered from significant underinvestment and required substantial capital expenditures beyond stated estimates [5]. - It is claimed that there were significant manufacturing deficiencies in Perrigo's infant formula facility, leading to overstated financial results, including earnings and cash flow, and that positive statements about the company's business were materially misleading [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, noting its history of achieving significant settlements for investors, including over $438 million in 2019 alone [4]. - The firm has been recognized for its leadership in securities class action settlements, being ranked No. 1 by ISS Securities Class Action Services in 2017 and consistently in the top 4 since 2013 [4].

Core Points - A class action lawsuit has been filed against Perrigo Company plc and certain officers for alleged violations of federal securities laws during the period from February 27, 2025, to November 4, 2025 [2][4] Group 1: Allegations - The lawsuit claims that Perrigo's management made materially false and misleading statements and failed to disclose significant adverse facts about the company's business and operations [3] - Specific allegations include underinvestment in the infant formula business acquired from Nestlé, the need for substantial capital expenditures beyond stated estimates, and significant manufacturing deficiencies [3] - As a result of these issues, the company's financial results, including earnings and cash flow, were overstated, leading to misleading positive statements about its business prospects [3] Group 2: Legal Process - Investors who suffered losses in Perrigo have until January 16, 2026, to request to be appointed as lead plaintiff in the class action [4] - The law firm representing the investors operates on a contingency fee basis, meaning they will only collect fees if the case is successful [5][6]

Core Insights - Perrigo Company plc is facing a class action lawsuit for investors who purchased securities between February 27, 2023, and November 4, 2025, with a deadline for filing a lead plaintiff motion set for January 16, 2026 [1][2] - On November 5, 2025, Perrigo announced a strategic review of its infant formula business, which includes evaluating alternatives to enhance cash flows and reassessing a previously announced investment of $240 million in this sector [3] - Following the announcement of the strategic review, Perrigo's stock price dropped by $5.09, or 25.21%, closing at $15.10 per share on the same day [3] Legal Context - The Portnoy Law Firm is representing investors in claims related to corporate wrongdoing, emphasizing their experience in recovering over $5.5 billion for affected investors [4]

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Perrigo Company plc securities, alleging that the company made materially false and misleading statements regarding its infant formula business and financial results during the class period from February 27, 2023, to November 4, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Perrigo's infant formula business, acquired from Nestlé, suffered from significant underinvestment in maintenance and required substantial capital and operational expenditures beyond previously stated estimates [5]. - It is alleged that there were significant manufacturing deficiencies in Perrigo's infant formula facility, leading to overstated financial results, including earnings and cash flow [5]. - The lawsuit asserts that the positive statements made by Perrigo regarding its business operations and prospects were materially misleading and lacked a reasonable basis [5]. Group 2: Participation Information - Investors who purchased Perrigo securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, investors can visit the provided link or contact Phillip Kim, Esq. for more information [3][6]. - A lead plaintiff must move the court by January 16, 2026, to represent other class members in directing the litigation [1][3].

Nov 19, 2025 12:06 PM Eastern Standard Time Law Offices of Frank R. Cruz Encourages Perrigo Company plc (PRGO) Shareholders To Inquire About Securities Fraud Class Action Share IF YOU SUFFERED A LOSS ON YOUR PERRIGO COMPANY PLC (PRGO) INVESTMENTS, CLICK HERE TO SUBMIT A CLAIM TO POTENTIALLY RECOVER YOUR LOSSES IN THE ONGOING SECURITIES FRAUD LAWSUIT. You can also contact the Law Offices of Frank R. Cruz to discuss your legal rights by email at info@frankcruzlaw.com, by telephone at (310) 914-5007, or visit ...

ATLANTA, Nov. 19, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Perrigo Company plc (“Perrigo”) (NYSE: PRGO). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose key facts, including allegations that: (1) the infant formula business acquired from Nestlé suffered from significant underinvestment in maintenance, operational improvements, and repairs; (2) Perrigo needed to make substantial capital and operational ...